Regulations.gov document
PSG_217581 - Draft Guidance on Crizotinib
Other · FDA-2007-D-0369 · posted Oct 2, 2025
Key facts
| Document ID | FDA-2007-D-0369-2192 |
|---|---|
| Title | PSG_217581 - Draft Guidance on Crizotinib |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2007-D-0369 |
| Posted | Oct 2, 2025 |
| Comment period opens | Oct 2, 2025 |
| Comments due | Dec 2, 2025 |
At a glance
- No Open for comment
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: